Keros Therapeutics (KROS) Financials: Revenue & Earnings

KROS price $11.69 +0.27 +2.32%

Ticker
KROS
Price
$11.69
Change
+0.27 +2.32%
Market cap ?
$231.78M
Beta ?
1.02
Sector
Healthcare
Industry
Biotechnology

Fair value

KROS fair value $89.91. Price $11.69. Price is 87% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare KROS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.96—14.76M
2026-08-03-1.45-1.34—807.14K
2026-05-14-1.21-0.92367.00K1.93M
2026-03-04-0.86-0.49385.00K3.67M
2025-11-05-0.18-1.1114.26M3.66M
2025-08-06-0.76-1.1418.17M3.21M
2025-05-063.62-0.01211.25M56.65M
2025-02-26-1.14-1.363.04M22.23M
2024-11-06-1.41-1.26388.00K2.31M
2024-08-07-1.25-1.2337.00K—
2024-05-08-1.21-1.3183.00K—
2024-02-28-1.34-1.38143.00K—
2023-11-06-1.33-1.348.00K—
2023-08-07-1.27-1.34—160.00K
2023-05-04-1.26-1.13—220.00K
2023-03-03-1.09-1.12—1.20M
2022-11-03-0.92-1.26——
2022-08-04-1.13-1.07100.00K—
2022-05-05-1.01-0.86—6.00M
2022-03-09-0.30-0.9420.00M—
2021-11-04-0.87-0.72——
2021-08-05-0.67-0.66100.00K100.00K
2021-05-06-0.68-0.58——
2021-03-25-0.49-0.57——
2020-11-10-0.60-0.582.50M—
2020-08-13-0.62-0.512.50M—
2020-05-22-5.11-0.372.50M—
2020-04-08-0.31—2.50M—
2019-09-30-0.40—2.50M—
2019-06-30-0.32—2.50M—
2019-03-31-0.36—2.50M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-18Tanini AnnitaSell1.22K$10.2912.59K
2026-08-18Lerner Lorena RaquelSell3.57K$10.2936.71K
2026-08-18Cho EstherSell4.49K$10.2946.15K
2026-08-18Newton Charles W.Sell551$10.305.68K
2026-08-17BIENAIME JEAN JACQUESBuy1.00K$10.2710.27K
2026-08-04Tanini AnnitaOther0——
2026-08-04Tanini AnnitaOther7.50K$46.30347.25K
2026-08-04Tanini AnnitaOther25.00K$28.74718.50K
2026-08-04Tanini AnnitaOther6.00K$70.93425.58K
2026-08-04Tanini AnnitaOther10.00K$54.38543.80K
2026-08-04Tanini AnnitaOther14.80K$56.18831.46K
2026-08-04Tanini AnnitaOther7.80K$15.52121.06K
2026-07-15BIENAIME JEAN JACQUESBuy1.00K$10.6110.61K
2026-07-01Prener AnneBuy14.87K$10.88161.79K
2026-07-01Prener AnneBuy13.79K——
2026-07-01Prener AnneOther0——
2026-06-15BIENAIME JEAN JACQUESBuy1.00K$10.1910.19K
2026-06-11Newton Charles W.Sell550$10.045.52K
2026-06-04Farzan NimaSell2.62K$10.7328.17K
2026-06-04Knowles JuliusSell2.62K$10.7328.17K
2026-06-04Seth AlpnaSell2.62K$10.7228.14K
2026-06-03Seth AlpnaBuy7.14K——
2026-06-03Seth AlpnaBuy7.43K$10.5078.05K
2026-06-03GRAY MARY ANNBuy7.14K——
2026-06-03GRAY MARY ANNBuy7.43K$10.5078.05K
2026-06-03Farzan NimaBuy7.14K——
2026-06-03Farzan NimaBuy7.43K$10.5078.05K
2026-06-03BIENAIME JEAN JACQUESBuy7.14K——
2026-06-03BIENAIME JEAN JACQUESBuy7.43K$10.5078.05K
2026-06-03Knowles JuliusBuy7.14K——
2026-06-03Knowles JuliusBuy7.43K$10.5078.05K
2026-05-15BIENAIME JEAN JACQUESBuy1.00K$10.5810.58K
2026-04-15BIENAIME JEAN JACQUESBuy1.00K$11.7011.70K
2026-04-02Seehra JasbirBuy55.00K$0.3016.50K
2026-04-02Seehra JasbirSell55.00K$0.3016.50K
2026-03-09Newton Charles W.Buy14.79K$11.35167.84K
2026-03-09Newton Charles W.Buy13.21K——
2026-03-09Newton Charles W.Other0——
2026-03-09BIENAIME JEAN JACQUESBuy2.00K$11.2122.42K
2026-02-24Cho EstherBuy80.00K$15.521.24M
2026-02-24Seehra JasbirBuy217.00K$15.523.37M
2026-02-24Seehra JasbirBuy100.00K$15.521.55M
2026-02-24Regnante KeithBuy60.00K$15.52931.20K
2026-02-19Seehra JasbirSell7.01K$16.17113.43K
2026-02-18Lerner Lorena RaquelSell3.87K$16.3563.32K
2026-02-18Cho EstherSell4.75K$16.3577.58K
2026-02-18Regnante KeithSell4.74K$16.3577.48K
2026-01-07Seehra JasbirBuy62.50K$63.613.98M
2025-11-21ORBIMED ADVISORS LLCSell140.06K$17.752.49M
2025-11-21ORBIMED ADVISORS LLCSell74.47K$17.751.32M
2025-11-21GORDON CARL LSell140.06K$17.752.49M
2025-11-21GORDON CARL LSell74.47K$17.751.32M
2025-11-21Knowles JuliusSell191.53K$17.753.40M
2025-11-21Knowles JuliusSell130.49K$17.752.32M
2025-10-15Pontifax Management 4 G.P. (2015) Ltd.Sell155.26K$17.752.76M
2025-10-15ADAR1 Capital Management, LLCSell743.36K$17.7513.19M
2025-09-03Seehra JasbirBuy90.50K——
2025-08-06Lerner Lorena RaquelOther0——
2025-08-06Lerner Lorena RaquelOther23.00K$56.181.29M
2025-08-06Lerner Lorena RaquelOther7.50K$54.38407.85K
2025-08-06Lerner Lorena RaquelOther10.88K$43.99478.57K
2025-08-06Cho EstherOther0——
2025-08-06Cho EstherOther50.00K$56.182.81M
2025-08-06Cho EstherOther20.97K$29.02608.49K
2025-08-06Cho EstherOther20.00K$70.931.42M
2025-08-06Cho EstherOther25.00K$46.301.16M
2025-08-06Cho EstherOther50.00K$54.382.72M
2025-06-20ADAR1 Capital Management, LLCSell100$60.006.00K
2025-06-20ADAR1 Capital Management, LLCSell1.40K$70.0098.00K
2025-06-20ADAR1 Capital Management, LLCSell200$70.0014.00K
2025-06-20ADAR1 Capital Management, LLCSell2$70.00140
2025-06-20ADAR1 Capital Management, LLCSell1$60.0060
2025-06-04Kariv TomerOther0——
2025-06-04Nussbaum RanOther0——
2025-06-04Knowles JuliusBuy10.50K$14.82155.61K
2025-06-04Knowles JuliusBuy5.25K——
2025-06-04GORDON CARL LBuy10.50K$14.82155.61K
2025-06-04GORDON CARL LBuy5.25K——
2025-06-04Kariv TomerBuy10.50K$14.82155.61K
2025-06-04Farzan NimaBuy10.50K$14.82155.61K
2025-06-04Kariv TomerBuy5.25K——
2025-06-04Farzan NimaBuy5.25K——
2025-06-04Nussbaum RanBuy10.50K$14.82155.61K
2025-06-04Nussbaum RanBuy5.25K——
2025-06-04Seth AlpnaBuy10.50K$14.82155.61K
2025-06-04Seth AlpnaBuy5.25K——
2025-06-04GRAY MARY ANNBuy10.50K$14.82155.61K
2025-06-04GRAY MARY ANNBuy5.25K——
2025-06-04BIENAIME JEAN JACQUESBuy10.50K$14.82155.61K
2025-06-04BIENAIME JEAN JACQUESBuy5.25K——
2025-05-16ADAR1 Capital Management, LLCSell178$10.001.78K
2025-04-09ADAR1 Capital Management, LLCBuy74.33K$10.33767.86K
2025-04-09ADAR1 Capital Management, LLCBuy500.00K$10.335.17M
2025-04-09ADAR1 Capital Management, LLCBuy325.00K$9.863.20M
2025-04-09ADAR1 Capital Management, LLCBuy18.56K$9.40174.37K
2025-04-09ADAR1 Capital Management, LLCBuy16.36K$9.40153.75K
2025-04-09ADAR1 Capital Management, LLCSell325.00K——
2025-04-09ADAR1 Capital Management, LLCSell500.00K——
2025-04-09ADAR1 Capital Management, LLCSell74.33K——
2025-04-08ADAR1 Capital Management, LLCOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 134, holders -22 vs prior quarter. Ownership 94.51%.

HolderSharesChangeChange %Value
BLACKROCK, INC.2.79M382.42K+15.86%29.90M
NANTAHALA CAPITAL MANAGEMENT, LLC1.41M50.00K+3.68%15.09M
AQR CAPITAL MANAGEMENT LLC967.86K561.30K+138.06%10.36M
VANGUARD CAPITAL MANAGEMENT LLC833.60K2.17K+0.26%8.92M
ORBIMED ADVISORS LLC759.15K00.00%8.12M
FEDERATED HERMES, INC.700.43K11.20K+1.62%7.49M
VANGUARD PORTFOLIO MANAGEMENT LLC652.63K-29.41K-4.31%6.98M
MACKENZIE FINANCIAL CORP628.44K475.99K+312.23%6.72M
MADISON AVENUE PARTNERS, LP626.58K00.00%6.70M
QUBE RESEARCH & TECHNOLOGIES LTD608.84K-116.09K-16.01%6.51M
JACOBS LEVY EQUITY MANAGEMENT, INC605.45K-100.63K-14.25%6.48M
STATE STREET CORP541.19K-20.54K-3.66%5.79M
GEODE CAPITAL MANAGEMENT, LLC510.84K-170.62K-25.04%5.47M
DIMENSIONAL FUND ADVISORS LP460.54K139.18K+43.31%4.93M
CITADEL ADVISORS LLC396.10K378.90K+2202.90%4.24M
RENAISSANCE TECHNOLOGIES LLC359.09K-94.40K-20.82%3.84M
D. E. SHAW & CO., INC.267.46K-242.15K-47.52%2.86M
BRIDGEWAY CAPITAL MANAGEMENT, LLC265.02K70.00K+35.89%2.84M
NUVEEN, LLC247.76K-14.32K-5.46%2.65M
ADAR1 CAPITAL MANAGEMENT, LLC246.82K149.50K+153.62%2.64M
TWO SIGMA INVESTMENTS, LP246.65K-117.19K-32.21%2.64M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP233.18K-357.07K-60.50%2.49M
MILLENNIUM MANAGEMENT LLC184.82K77.96K+72.96%1.98M
GOLDMAN SACHS GROUP INC177.85K-46.63K-20.77%1.90M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.158.71K158.71KNew1.70M

Earnings and financials

Keros Therapeutics, Inc. (KROS) trades at $11.69, with a market cap of $231.78M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Keros Therapeutics (KROS) Financials: Revenue & Earnings

KROS$11.69+0.27 +2.32%

$231.78M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History